Johnson, S. R., Bernstein, E. J., Bolster, M. B., Chung, J. H., Danoff, S. K., George, M. D., Khanna, D., Guyatt, G., Mirza, R. D., Aggarwal, R., Allen, A., Assassi, S., Buckley, L., Chami, H. A., Corwin, D. S., Dellaripa, P. F., Domsic, R. T., Doyle, T. J., Falardeau, C. M., … Ivlev, I. (2024). 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis & Rheumatology, 76(8), 1182–1200. Portico. https://doi.org/10.1002/art.42861

Johnson, S. R., Bernstein, E. J., Bolster, M. B., Chung, J. H., Danoff, S. K., George, M. D., Khanna, D., Guyatt, G., Mirza, R. D., Aggarwal, R., Allen, A., Assassi, S., Buckley, L., Chami, H. A., Corwin, D. S., Dellaripa, P. F., Domsic, R. T., Doyle, T. J., Falardeau, C. M., … Ivlev, I. (2024). 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis & Rheumatology, 76(8), 1201–1213. Portico. https://doi.org/10.1002/art.42860

Johnson, S. R., Bernstein, E. J., Bolster, M. B., Chung, J. H., Danoff, S. K., George, M. D., Khanna, D., Guyatt, G., Mirza, R. D., Aggarwal, R., Allen, A., Assassi, S., Buckley, L., Chami, H. A., Corwin, D. S., Dellaripa, P. F., Domsic, R. T., Doyle, T. J., Falardeau, C. M., … Ivlev, I. (2024). 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care & Research, 76(8), 1051–1069. Portico. https://doi.org/10.1002/acr.25348

Johnson, S. R., Bernstein, E. J., Bolster, M. B., Chung, J. H., Danoff, S. K., George, M. D., Khanna, D., Guyatt, G., Mirza, R. D., Aggarwal, R., Allen, A., Assassi, S., Buckley, L., Chami, H. A., Corwin, D. S., Dellaripa, P. F., Domsic, R. T., Doyle, T. J., Falardeau, C. M., … Ivlev, I. (2024). 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care & Research, 76(8), 1070–1082. Portico. https://doi.org/10.1002/acr.25347

Allen, M. R., Alevizos, M. K., Zhang, D., & Bernstein, E. J. (2023). Performance of GAP and ILD-GAP models in predicting lung transplant or death in interstitial pneumonia with autoimmune features. Rheumatology, 63(6), 1568–1573. https://doi.org/10.1093/rheumatology/kead428

Bernstein, E. J., Denton, C. P., Huang, S., & Khanna, D. (2024). Baseline absolute monocyte count predicts lung function decline among patients with systemic sclerosis-associated interstitial lung disease: A post hoc analysis from the focuSSced trial. Seminars in Arthritis and Rheumatism, 65, 152376. https://doi.org/10.1016/j.semarthrit.2024.152376

Rahaghi, F. F., Hsu, V. M., Kaner, R. J., Mayes, M. D., Rosas, I. O., Saggar, R., Steen, V. D., Strek, M. E., Bernstein, E. J., Bhatt, N., Castelino, F. V., Chung, L., Domsic, R. T., Flaherty, K. R., Gupta, N., Kahaleh, B., Martinez, F. J., Morrow, L. E., Moua, T., … Khanna, D. (2023). Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respiratory Research, 24(1). https://doi.org/10.1186/s12931-022-02292-3

Singer, D., Chastek, B., Sargent, A., Johnson, J. C., Shetty, S., Conoscenti, C., & Bernstein, E. J. (2023). Impact of chronic fibrosing interstitial lung disease on healthcare use: association between fvc decline and inpatient hospitalization. BMC Pulmonary Medicine, 23(1). https://doi.org/10.1186/s12890-023-02637-8

Zhang, D., Adegunsoye, A., Oldham, J. M., Kozlitina, J., Garcia, N., Poonawalla, M., Strykowski, R., Linderholm, A. L., Ley, B., Ma, S.-F., Noth, I., Strek, M. E., Wolters, P. J., Garcia, C. K., & Newton, C. A. (2023). Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. European Respiratory Journal, 62(5), 2300441. https://doi.org/10.1183/13993003.00441-2023

Correa-Jimenez, O., Restrepo-Gualteros, S., Nino, G., Cunningham-Rundles, C., Sullivan, K. E., Fuleihan, R. L., & Gutierrez, M. J. (2023). Respiratory Comorbidities Associated with Bronchiectasis in Patients with Common Variable Immunodeficiency in the USIDNET Registry. Journal of Clinical Immunology, 43(8), 2208–2220. https://doi.org/10.1007/s10875-023-01593-6

Case, A. H., Beegle, S., Hotchkin, D. L., Kaelin, T., Kim, H. J., Podolanczuk, A. J., Ramaswamy, M., Remolina, C., Salvatore, M. M., Tu, C., & de Andrade, J. A. (2023). Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey. BMJ Open Respiratory Research, 10(1), e001594. https://doi.org/10.1136/bmjresp-2022-001594

Matkovic Leko, I., Schneider, R. T., Thimraj, T. A., Schrode, N., Beitler, D., Liu, H.-Y., Beaumont, K., Chen, Y.-W., & Snoeck, H.-W. (2023). A distal lung organoid model to study interstitial lung disease, viral infection and human lung development. Nature Protocols, 18(7), 2283–2312. https://doi.org/10.1038/s41596-023-00827-6

Kim, J. S., Manichaikul, A. W., Hoffman, E. A., Balte, P., Anderson, M. R., Bernstein, E. J., Madahar, P., Oelsner, E. C., Kawut, S. M., Wysoczanski, A., Laine, A. F., Adegunsoye, A., Ma, J. Z., Taub, M. A., Mathias, R. A., Rich, S. S., Rotter, J. I., Noth, I., Garcia, C. K., … Podolanczuk, A. J. (2022). MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study. Thorax, 78(6), 566–573. https://doi.org/10.1136/thorax-2021-218139

Roofeh, D., Brown, K. K., Kazerooni, E. A., Tashkin, D., Assassi, S., Martinez, F., Wells, A. U., Raghu, G., Denton, C. P., Chung, L., Hoffmann-Vold, A.-M., Distler, O., Johannson, K. A., Allanore, Y., Matteson, E. L., Kawano-Dourado, L., Pauling, J. D., Seibold, J. R., Volkmann, E. R., … Khanna, D. (2022). Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease. Rheumatology, 62(5), 1877–1886. https://doi.org/10.1093/rheumatology/keac557

Kim, J. S., Azarbarzin, A., Podolanczuk, A. J., Anderson, M. R., Cade, B. E., Kawut, S. M., Wysoczanski, A., Laine, A. F., Hoffman, E. A., Gottlieb, D. J., Garcia, C. K., Barr, R. G., & Redline, S. (2023). Obstructive Sleep Apnea and Longitudinal Changes in Interstitial Lung Imaging and Lung Function: The MESA Study. Annals of the American Thoracic Society, 20(5), 728–737. https://doi.org/10.1513/annalsats.202208-719oc

Shou, A. Y., & Salvatore, M. M. (2023). CT predictors of outcomes in patients with connective tissue disease and progressive lung fibrosis. Clinical Imaging, 94, 42–49. https://doi.org/10.1016/j.clinimag.2022.11.022

Pugashetti, J. V., Adegunsoye, A., Wu, Z., Lee, C. T., Srikrishnan, A., Ghodrati, S., Vo, V., Renzoni, E. A., Wells, A. U., Garcia, C. K., Chua, F., Newton, C. A., Molyneaux, P. L., & Oldham, J. M. (2023). Validation of Proposed Criteria for Progressive Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 207(1), 69–76. https://doi.org/10.1164/rccm.202201-0124oc

Kim, J. S., Kim, J., Yin, X., Hiura, G. T., Anderson, M. R., Hoffman, E. A., Raghu, G., Noth, I., Manichaikul, A., Rich, S. S., Smith, B. M., Podolanczuk, A. J., Garcia, C. K., Barr, R. G., Prince, M. R., & Oelsner, E. C. (2022). Associations of hiatus hernia with CT-based interstitial lung changes: the MESA Lung Study. European Respiratory Journal, 61(1), 2103173. https://doi.org/10.1183/13993003.03173-2021

Syed, M. N., Kutac, C., Miller, J. M., Marsh, R., Sullivan, K. E., Cunningham-Rundles, C., Fuleihan, R. L., Kheradmand, F., & Hajjar, J. (2022). Risk Factors of Pneumonia in Primary Antibody Deficiency Patients Receiving Immunoglobulin Therapy: Data from the US Immunodeficiency Network (USIDNET). Journal of Clinical Immunology, 42(7), 1545–1552. https://doi.org/10.1007/s10875-022-01317-2

Bruni, C., Chung, L., Hoffmann-Vold, A. M., Assassi, S., Gabrielli, A., Khanna, D., Bernstein, E. J., & Distler, O. (2021). High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey. Clinical and Experimental Rheumatology. https://doi.org/10.55563/clinexprheumatol/7ry6zz

Lee, J., White, E., Freiheit, E., Scholand, M. B., Strek, M. E., Podolanczuk, A. J., Patel, N. M., Bascom, R., Belloli, E., Bhatt, N., Bhorade, S., Case, A., Castriotta, R., Criner, G., Danoff, S., De Andrade, J., Desai, A., Glassberg, M., Glazer, C., … Wolters, P. (2022). Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease. CHEST, 162(3), 603–613. https://doi.org/10.1016/j.chest.2022.03.025

Nosotti, M., Leiva-Juarez, M., D’Ovidio, F., Van Raemdonck, D., Ceulemans, L., Keshavjee, S., Rackauskas, M., Paladini, P., Luzzi, L., Casado, P. M., Alvarez, A., Inci, I., Ehrsam, J., Krueger, T., Roth, A., Rea, F., Schiavon, M., & Rosso, L. (2022). Survival After Lung Transplantation for Chronic Hypersensitivity Pneumonitis: Results From a Large International Cohort Study. Transplant International, 35. https://doi.org/10.3389/ti.2022.10450

Kim, J. S., Axelsson, G. T., Moll, M., Anderson, M. R., Bernstein, E. J., Putman, R. K., Hida, T., Hatabu, H., Hoffman, E. A., Raghu, G., Kawut, S. M., Doyle, M. F., Tracy, R., Launer, L. J., Manichaikul, A., Rich, S. S., Lederer, D. J., Gudnason, V., Hobbs, B. D., … Podolanczuk, A. J. (2022). Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities. American Journal of Respiratory and Critical Care Medicine, 205(7), 795–805. https://doi.org/10.1164/rccm.202108-1967oc

Bowman, W. S., Newton, C. A., Linderholm, A. L., Neely, M. L., Pugashetti, J. V., Kaul, B., Vo, V., Echt, G. A., Leon, W., Shah, R. J., Huang, Y., Garcia, C. K., Wolters, P. J., & Oldham, J. M. (2022). Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis. The Lancet Respiratory Medicine, 10(6), 593–602. https://doi.org/10.1016/s2213-2600(21)00503-8

Popmihajlov, Z., Sutherland, D. J., Horan, G. S., Ghosh, A., Lynch, D. A., Noble, P. W., Richeldi, L., Reiss, T. F., & Greenberg, S. (2022). CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial. BMJ Open Respiratory Research, 9(1), e001060. https://doi.org/10.1136/bmjresp-2021-001060